Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

beareclawe 579 posts  |  Last Activity: 10 hours ago Member since: Jan 10, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    22 patients treated. Here are the results.

    by efficacy_20_40 Jun 4, 2015 11:51 PM
    beareclawe beareclawe Jul 31, 2015 6:58 AM Flag

    Re: What is truth ?

    biosectinvestor • Jul 25, 2015 4:06 PM
    Welcome Paid Bashers
    We know you get paid to be here. Don't worry, it's obvious.

    beareclawe • Jul 26, 2015 6:51 AM
    Re: Welcome Paid Bashers We know you get paid to be here...
    Who dat ?
    When I say 'Who dat ?' ...... Who dat ?
    : ) Life begins where land ends !

    biosectinvestor • Jul 29, 2015 8:26 AM
    You've been here for years, on this obscure board, posting the same messages every day, since before 2008, 24/7/365. There is enough information already out there, to know this is the reality.

    beareclawe • Jul 29, 2015 5:50 PM
    Re: You've been here for years, on this obscure board, posting the same messages every day, since before 2008, 24/7/365.

    Counselor, you're inaccurate and you should know better than to present unsubstantiated allegations.

    Reply to A one time post....ex-associate of Goldbyar by goldsafake •Jun 18, 2009 4:56 PM
    biosectinvestor • Jun 21, 2009 10:38 PM
    (excerpt)
    I'm a decent sized investor in ACTC. I also happen to be knowledgeable about legal issue relating to securities and know about all the shorts on this stock. Sometimes, allegations like yours are true, but they also can simply be another tactic used to cause doubt amongst new investors in a stock, with the purpose of manipulation of that stock, rather than true allegations.

    : ) Care to comment, counselor ?

  • Reply to

    22 patients treated. Here are the results.

    by efficacy_20_40 Jun 4, 2015 11:51 PM
    beareclawe beareclawe Jul 31, 2015 6:48 AM Flag

    Re: The truth is . . .

    What is truth ?

    : )

  • beareclawe beareclawe Jul 31, 2015 6:43 AM Flag

    Re: this could be a 500.00 a share stock ...

    Nah, How about ..........

    pyar_hi_pyar_ha • Apr 3, 2015 1:33 PM
    OCATA Therapeutics PPS projections based on TOTAL ADDRESSABLE MARKET(TAM) for Pivotal SMD and Phase 2 AMD and upcoming milestones 2015/2016

    (excerpt)

    2nd quarter 2015: $35.00 plus ...
    3rd quarter 2015: $70.00 plus ...
    4th quarter 2015: $ 100.00+ ...
    2016 to be continued...

    : )
    .

  • beareclawe beareclawe Jul 31, 2015 6:02 AM Flag

    Re: this could be a 500.00 a share stock ...

    Nah........ How about $4000 ?

    rainmanshere • Jul 29, 2015 4:46 PM
    Freddy,we're now fighting to hold $4.00 a share. GET BACK TO WORK ! You've got to turn this thing around. We're all counting on you. Tell some Ocata stories, list the institutional buyers again, something, anything but GET BACK TO WORK ! You promised us $4000 a share little shaver. Make us proud.

    : ) Giddy up !

  • beareclawe beareclawe Jul 31, 2015 5:41 AM Flag

    Re: freddy...

    " Yes I bought under $6... I try to buy some every time its under $6 "

    Citation:

    freddyaophelps • Feb 5, 2015 1:18 PM
    Re:while it lasted.............Toodles

    Dec 3, 2014 OCAT Prices
    Open $6.10
    High $6.23
    Low $5.85
    Close $5.96

    Yes I bought under $6... I try to buy some every time its under $6
    spamcan you really need to get a better information source than Yahoo Finance.

    : ) CHA$E IT ! CHA$E IT ! CHA$E IT !

  • beareclawe beareclawe Jul 31, 2015 4:54 AM Flag

    Re: this could be a 500.00 a share stock ...

    Nah, how about $450 ?

    Reply to OCAT shares are about to break out to $25.00+ by 03/31/2015, Bidding war for the RPE cell therapy, JV announcement imminent AMGN SNY GE by tony_montello2003 •Mar 6, 2015 12:37 AM
    tony_montello2003 • Mar 8, 2015 11:17 PM
    $450.00+ if not bought out by Big PHARMA before that.)
    OCAT is future of Medicine,
    Dr. Tony Montello.
    Sentiment: Strong Buy

    tony_montello2003 • Mar 6, 2015 12:37 AM
    OCAT shares are about to break out to $25.00+ by 03/31/2015, Bidding war for the RPE cell therapy, JV announcement imminent AMGN SNY GE
    This topic is deleted.

    : )

  • beareclawe beareclawe Jul 31, 2015 4:41 AM Flag

    Re: Phase trials require more then one person...

    "The second thing is towards the end of December, early part of the year, we started realizing that we'd have to change the way we designed our clinical trials to include control patients, ..."

    Conference Call & Webcast, Corporate Update, March 12, 2015

    Paul Wotton: Well, the question really is about the progress we're making on the clinical trial front, and the important thing that we learned over the last quarter. There's a number of things that happened, the first is we have positive data from the Lancet. The second thing is towards the end of December, early part of the year, we started realizing that we'd have to change the way we designed our clinical trials to include control patients, which actually just changed the way that people view our company. We did have a meeting with the European Medicines Agency February 4th of this year, and as a result of that meeting, as well as continued dialogue we've had with other agencies, we have changed the design of both the dry AMD study and the Stargardt's disease study to ensure that we include a control group of patients, which we believe will give us a better outcome. It also harmonizes, we think, the studies between what the FDA will require for approval and what the European Agencies will require for approval, and as we mentioned on the call as well, we are also looking into the possibility of getting a Special Protocol Assessment with the FDA, which will help to de-risk the programs that we are working on and make the approval process more expeditious for us. So what we've tried to do in the past quarter is focus quantitatively on improving the design of our clinical studies.

    : ) Wotton: D'oh !

  • beareclawe beareclawe Jul 30, 2015 10:23 AM Flag

    Re: I would Love to hear the merits of a RS from all the experts here......

    It's time for theresnobeachhere and ......

    the rabidly optimistic, unconscionable, and conjecture-based,
    hschlauch and the short and distort group,
    the anxious and desperate,
    the spin/pump chimps

    ........ to chime in.

    : )

  • beareclawe beareclawe Jul 30, 2015 7:55 AM Flag

    Re: Gathers up everyone else's posts and reconstitutes them and thinks that makes him look like one that's smart about wampum....

    nobeach,

    Have you had your maui beach filled 'sand sack' therapy session today ? Simple sand sack fuhrer/guru says ...

    FIGHTERPILOT Mar 27, 2012 3:38 PM
    Hate and envy
    It's not healthy. Those who suffer from this terrible condition, should consider replacing their MB posts with several hours a day punching a sand sack. You can write my ID on it or ACTC.

    Re: .... He must have a large data storage plan.

    Nope.... as usual, you're inaccurate.

    : ) Life begins where land ends !

  • beareclawe beareclawe Jul 30, 2015 6:59 AM Flag

    Re: biosectinvestor • Jul 29, 2015 1:02 AM
    Because you're an idiot. Why would someone be paying you to post endless bashing posts about this insignificant stock 24/7/365 for years on end, as long as I've been here nad invested, if this were so irrelevant. Cowen is a major investment bank, you numbskull. You bashers just spend days here with no clue, endlessly repeating and posting your talking points.

    'You should get back on those meds.'

    Citation:

    biosectinvestor • Jul 29, 2015 1:08 AM
    You should get back on those meds.

    Counselor...... It's hard to defeat an opponent when the demon is living inside your head. Just ask 'freddy)O(phelps the all seeing all knowing.'

    Citation:

    freddyaophelps • Apr 21, 2015 10:01 PM
    Thou doth protest too much. What further proof do I need?
    freddy)O(phelps the all seeing all knowing

    : )

  • beareclawe beareclawe Jul 30, 2015 6:43 AM Flag

    Re: markcyr326 • 8 hours ago
    It never goes up when you want it too, need to wait for Q3 data for phase 2 and partnership with blood platelet program, then we see SP start to move
    Sentiment: Strong Buy

    "...., Ocata will soar from this level." -- Dec 28, 2014 2:11 PM

    Citation:

    markcyr326 • Dec 28, 2014 2:11 PM
    It matters not what the naysayers have to say, we know they are disgruntled losers, Ocata will soar from this level. The next few weeks will be interesting!
    Sentiment: Strong Buy

    : ) Dec 29, 2014 / $6.20

  • Reply to

    Stressed out but still holding.

    by jssflash Jun 25, 2015 3:38 PM
    beareclawe beareclawe Jul 29, 2015 10:22 PM Flag

    Re: Bear, i'm still trying to figure you out after all this time, Steve

    theresnobeachhere • Jul 26, 2015 5:23 PM
    Good post. I've categorized most posters on this board into two groups - those who think everything is wrong with the company and those who feel everything is right. (Of course Beare is in his own category) reality is in between.

    rainmanshere • Jul 26, 2015 6:29 PM
    "(Of course Beare is in his own category) reality is in between."
    If you knew anything at all about bearecraft then you'd realize that beare doesn't need to believe in either side, or any side. For him there is no cause. There's only himself. The belief his in his own beare precision.

    : ) Life begins where land ends !

  • beareclawe beareclawe Jul 29, 2015 6:04 PM Flag

    Re: biosectinvestor • Jun 21, 2009 11:07 PM

    Do your own research.

    If you like a company, invest.

    Don't invest based upon short-term expectations unless you're a fool.

    Don't take the advice of anonymous posters.

    If you can't invest long term, and you don't believe in the company, PLEASE GET OUT OF IT.

    Go invest somewhere where you can understand what you are buying and you are more comfortable.

    This stock is NOT FOR YOU, and this kind of stock is not for you. It's too damn risky.

    Get out, day traders.

    : ) duplicity

  • Reply to

    Welcome Paid Bashers

    by biosectinvestor Jul 25, 2015 4:06 PM
    beareclawe beareclawe Jul 29, 2015 5:50 PM Flag

    Re: You've been here for years, on this obscure board, posting the same messages every day, since before 2008, 24/7/365.

    Counselor, you're inaccurate and you should know better than to present unsubstantiated allegations.

    Reply to A one time post....ex-associate of Goldbyar by goldsafake •Jun 18, 2009 4:56 PM
    biosectinvestor • Jun 21, 2009 10:38 PM
    (excerpt)
    I'm a decent sized investor in ACTC. I also happen to be knowledgeable about legal issue relating to securities and know about all the shorts on this stock. Sometimes, allegations like yours are true, but they also can simply be another tactic used to cause doubt amongst new investors in a stock, with the purpose of manipulation of that stock, rather than true allegations.

    : )

  • beareclawe beareclawe Jul 29, 2015 12:14 PM Flag

    Re: We believe that it is not possible at this stage to provide a meaningful estimate of the total cost to complete our ongoing projects and bring any proposed products to market.

    Yea, remember the myoblast program ?

    The "myoblast program for the treatment of heart failure" ...... "Feasible and safe" ..... "large market potential" ...... "approved for Phase II clinical trial."

    Unfortunately, the Company "suspended that program indefinitely due to a lack of funding."

    Citations:

    03/16/10 10-K Annual report pursuant to section 13 and 15(d)
    (excerpt)
    The company has secured Food and Drug Administration (FDA) clearance to proceed to a Phase II clinical trial for its Myoblast program for the treatment of heart failure, and the trial is currently being developed. We believe that the company's myoblast technology has demonstrated that a myoblast transplantation treatment is feasible and safe in clinical trials conducted to date and that the technology could address the large market potential presented by heart failure.

    05/07/10 10-Q Quarterly report pursuant to sections 13 or 15(d)
    (excerpt)
    Although our adult stem cell myoblast program has been approved for a Phase II clinical trial, we have suspended that program indefinitely due to a lack of funding.

    : )

  • beareclawe beareclawe Jul 29, 2015 11:30 AM Flag

    Re: this should stay on top so all shareholders are aware of the truth

    NCT01345006 (SMD) This study is ongoing, but not recruiting participants.
    NCT01344993 (Dry AMD) This study is ongoing, but not recruiting participants.
    NCT02122159 (MMD) This study is not yet open for participant recruitment.
    NCT01469832 (SMD/UK) This study is ongoing, but not recruiting
    participants.

    OCATA: "We believe that it is not possible at this stage to provide a meaningful estimate of the total cost to complete our ongoing projects and bring any proposed products to market."

    Citation:

    05/07/15 10-Q
    Research and Development Expenses
    (excerpt)

    We believe that it is not possible at this stage to provide a meaningful estimate of the total cost to complete our ongoing projects and bring any proposed products to market. The use of human embryonic stem cells as a therapy is an emerging area of medicine, and it is not known what clinical trials will be required by the U.S. Food and Drug Administration, or FDA, in order to gain marketing approval. Costs to complete could vary substantially depending upon the projects selected for development, the number of clinical trials required and the number of patients needed for each study. It is possible that the completion of these studies could be delayed for a variety of reasons, including difficulties in enrolling patients, delays in manufacturing, incomplete or inconsistent data from the pre-clinical or clinical trials, and difficulties evaluating the trial results. Any delay in completion of a trial would increase the cost of that trial, which would harm our results of operations. Due to these uncertainties, we cannot reasonably estimate the size, nature or timing of the costs to complete, or the amount or timing of the net cash inflows from, our current activities. Until we obtain further relevant pre-clinical and clinical data, we will not be able to estimate our future expenses related to these programs or when, if ever, and to what extent we will receive cash inflows from resulting products.

    : )

  • beareclawe beareclawe Jul 29, 2015 11:22 AM Flag

    Re: this should stay on top so all shareholders are aware of the truth

    Citations:

    Atala: "Much work remains to be done before hESC and induced pluripotent stem cell therapies go beyond regulatory trials,...."

    The Lancet, October 14, 2014
    Comment/Anthony Atala
    Wake Forest Institute for Regenerative Medicine, Wake Forest
    University School of Medicine, Winston-Salem, NC 27157, USA
    Human stem cell-derived retinal cells for macular diseases
    (excerpt)
    Much work remains to be done before hESC and induced pluripotent stem cell therapies go beyond regulatory trials, but the path is now set in motion.

    "....market potentially as early as 2019. "

    Press Release
    February 26, 2015
    Ocata Therapeutics Approved for Listing on NASDAQ
    (excerpt)
    The purpose of the pivotal SMD trial is to determine efficacy and safety, as well as to assess relevant functional and anatomical parameters of cell transplantation using an untreated control group, with the intent of bringing a product to market potentially as early as 2019.

    Wotton: "Over in Europe we believe we might be able to get that product to market towards the end of 2018, but we are targeting 2019."

    YouTube
    Dauphin Investor
    Roadshow: Ocata Therapeutics, Inc. (IPO)
    Published on Dec 6, 2014

    Lanza: "Any treatment might not be ready for FDA approval until 2020..."

    Tuesday, October 14, 2014
    Published study shows: ACT treatment restores some sight
    By Lisa Eckelbecker TELEGRAM & GAZETTE STAFF
    (excerpt)
    "We treated the last UK patients last month, and they also have not seen any safety issues related to the transplanted tissues themselves, either," Dr. Lanza said. Advanced Cell now hopes to launch a 100-patient, phase 2 study in Stargardt's patients by the end of the year, according to Dr. Lanza. A second, smaller phase 2 study in patients with age-related macular degeneration would follow, he said. Any treatment might not be ready for FDA approval until 2020, Dr. Lanza said.

    Schwartz: "It's not ready. Maybe in a few years. Maybe not. We have to wait and see. The jury is way out still."

    npr
    Embryonic Stem Cells Restore Vision In Preliminary Human Test
    Rob Stein
    October 14, 2014
    (excerpt)
    For his part, Schwartz says he's just trying to help blind people see better. But he cautions that this work is still at a very early stage. "I don't want patients to come in to their doctor saying, 'Hey, I heard about the stem cells on the radio and I'd really like to get that treatment done, and what do you think?' " he says. "It's not ready. Maybe in a few years. Maybe not. We have to wait and see. The jury is way out still."

    : )

  • beareclawe beareclawe Jul 29, 2015 10:56 AM Flag

    Re: ...... Here Are Some Facts

    06/17/15 424B5 Prospectus filed pursuant to Rule 424(b)(5)
    (excerpt)

    Corporate Information

    We were incorporated in Nevada under the name Two Moon Kachinas Corp. on May 18, 2000. On December 30, 2004, we changed our corporate name to A.C.T. Holdings, Inc. On January 31, 2005, we completed the acquisition of Advanced Cell Technology, Inc., a Delaware corporation, or ACT, pursuant to the terms of an Agreement and Plan of Merger dated December 31, 2004. On June 17, 2005, we changed our corporate name to Advanced Cell Technology, Inc. On November 18, 2005, we consummated a merger with and into our wholly-owned subsidiary ACT. As a result of the reincorporation, we became a Delaware corporation. On November 12, 2014, we changed our corporate name to Ocata Therapeutics, Inc.

    : ) With corporate rebranding, the Company can shed negative images of their past. They will rise like a phoenix from the ashes under the designation, Ocata Therapeutics Inc, and fleece another source (NASDAQ) of funding.

  • beareclawe beareclawe Jul 29, 2015 10:52 AM Flag

    Re: Let's get some cheap shares before anything is announced...

    Herd instinct investor$ wanted. Inform family and friends. Don't let 'em mi$$ the OCAT boat, bus, plane, or train.

    : ) Giddy up !

  • beareclawe beareclawe Jul 29, 2015 6:00 AM Flag

    Re: Don't take the advice of anonymous posters.

    "Let's get some cheap shares before anything is announced..."

    Citation:

    biosectinvestor • Jun 14, 2015 2:36 PM
    MM's Need to Take Out All The Stop Losses / and Puts for Cheap Shares Before News Hits
    Let's get some cheap shares before anything is announced...

    : )

ACTC
0.00(0.00%)